Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lifted by CreativeOne Wealth LLC

CreativeOne Wealth LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 87.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,986 shares of the medical equipment provider’s stock after buying an additional 2,331 shares during the period. CreativeOne Wealth LLC’s holdings in Intuitive Surgical were worth $2,602,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $28,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Finally, Summit Securities Group LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on ISRG shares. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Finally, Leerink Partners upped their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.7 %

Shares of NASDAQ:ISRG opened at $490.13 on Tuesday. The company has a market cap of $174.57 billion, a P/E ratio of 76.46, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The company’s fifty day moving average is $530.71 and its two-hundred day moving average is $532.76. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.